Christophe Weber

President & CEO, Takeda Pharmaceutical Company Limited

Christophe Weber is President, Chief Executive Officer (CEO) and Representative Director of Takeda Pharmaceutical Company Ltd. He joined the company in April 2014 as Chief Operating Officer, was named President and Representative Director in June 2014, and was subsequently appointed CEO in April 2015. Mr. Weber has focused on Takeda’s R&D transformation and globalization, creating a diverse and inclusive working environment while strengthening its ethical values and corporate governance. Through this transformation, Takeda became one of the leading global biopharmaceutical companies in the world.

Outside of Takeda, Mr. Weber is member of The Business Council, the World Economic Forum’s International Business Council, the Singapore Economic Development Board’s International Advisory Council, the New York Stock Exchange’s NYSE Board Advisory Council and the MIT CEO Advisory Board. He also serves on the Board of Trustees of Northeastern University.